Clinical Trials Logo

Filter by:
NCT ID: NCT02365792 Withdrawn - Clinical trials for Emergency Medical Services

Professional Development in Emergency Medical Services

ProDEms
Start date: June 2016
Phase: N/A
Study type: Interventional

The ProDEms-trial focuses on nurses and ambulance drivers working in prehospital care, taking care on the one hand of patients suffering from time-sensitive critical conditions like STEMI, acute stroke or severe traumatic brain injury, and on the other hand of patients whose lives are not in immediate danger but suffer from acute exacerbation of chronic conditions or suffer from acute pain. In the current study the investigators will use a multistage approach to test the hypothesis whether the use of a CDSS in prehospital emergency care will: 1. Improve protocol adherence, 2. Reduce emergency department length of stay, 3. Improves diagnostic accuracy; without impeding the workflow of the prehospital team or impairing patient safety.

NCT ID: NCT02338531 Withdrawn - Breast Cancer Clinical Trials

Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer

RHEA
Start date: June 2015
Phase: Phase 2
Study type: Interventional

This is a phase II open label Biomarker Research Study off PF-03084014 in non-metastatic triple-negative breast cancer patients with residual disease (cHEmoresistant) after completion of standard neoadjuvant chemotherapy.

NCT ID: NCT02324894 Withdrawn - Breast Cancer Clinical Trials

Initial Evaluation of Ultra FAST Breast Magnetic Resonance in Breast Cancer Screening: Comparative Study With Mammography and Ultrasound.

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

Mammography remains an imperfect screening test especially in women with extremely dense breast tissue, missing biologically aggressive cancers especially in younger population and picking up indolent cancers that do not need treatment. The most sensitive test for breast cancer detection at our disposal is magnetic resonance imaging (MRI). The preliminary study of Dr Kuhl provide strong arguments that Ultra FAST Breast Magnetic Resonance is suitable for breast cancer screening with high sensitivity and specificity values. Data clearly demonstrates that FAST breast MRI could be the standard for breast cancer screening: it is safe, does not induce cancers, and can find more cancers than mammography. However this study was performed in women with low to moderately increased risk.The value of FAST Breast Magnetic Resonance in normal screening population has to be assessed before a modification of current strategy of breast cancer screening with mammography.

NCT ID: NCT02314468 Withdrawn - Clinical trials for Necrotizing Soft Tissue Infection

Negative Pressure Wound Therapy and Allogeneic Human Skin Grafts for Wound Bed Preparation

NPWTvsGPA
Start date: October 2013
Phase: N/A
Study type: Interventional

Introduction Necrotising soft tissue infections (NSTI) incorporate a spectrum of pathologies, all characterized by an infectious state, typically arising after a penetrating trauma or a surgical procedure and an expeditious spreading of necrosis throughout the soft tissues of the body. It is a rare, life-threatening and devastating infection defined by a necrosis of fascia, subcutaneous tissues and skin. Aggressive surgical debridement to remove all necrotic tissue and define the extent of the disease is still the mainstay of correct treatment of NSTI. Both negative pressure wound therapy (NPWT) and the application of allograft skin to debrided areas, are documented options for wound bed preparation which are standard in the university hospital of Gent. NPWT is a technique for wound bed preparation involving the controlled application of sub-atmospheric pressure to the local wound environment, using a sealed wound dressing connected to a vacuum pump. Mechanisms of action attributed to NPWT include an increase in blood flow, promotion of angiogenesis, reduction in wound surface area, positive modulation of the inhibitory contents of wound fluid, induction of cell proliferation, reduction of edema, and bacterial clearance. Allograft skin or cadaveric skin possesses many of the ideal properties of biologic dressings, and plays a major role in the surgical management of extensive wounds when autologous tissue may not be immediately available. It reduces evaporative water loss and the drainage of protein-rich fluids, prevents wound desiccation, and suppresses microbial proliferation. Wound pain is lessened and the allograft restores a physiologic barrier at the wound surface. Enhancing revascularization, and thereby creating a viable wound bed before final reconstruction, is perceived as one of the most important features of allografting.

NCT ID: NCT02282176 Withdrawn - Clinical trials for Bronchopulmonary Dysplasia

TINN2: Treat Infection in NeoNates 2

TINN2
Start date: January 2015
Phase: Phase 3
Study type: Interventional

The aim of the TINN2 study is to evaluate the efficacy of azithromycin in prevention of bronchopulmonary dysplasia in preterm neonates.

NCT ID: NCT02274896 Withdrawn - Clinical trials for End Stage Renal Disease (ESRD)

Bayston Multicenter Antimicrobial PD Catheter Safety Study

Bayston
Start date: November 2014
Phase: N/A
Study type: Interventional

The study was designed to establish the safety of the Bayston Antimicrobial PD catheter that is impregnated with a "cocktail" of three well known anti-microbials

NCT ID: NCT02228018 Withdrawn - Asthma Clinical Trials

The Comparison of Electronic Auscultation Coupled With CALSA and FRI; Repeatability of FRI Biomarkers

Start date: March 2015
Phase: N/A
Study type: Interventional

CALSA will be compared with FRI and the repeatability of the FRI parameters will be tested in a group of healthy volunteers and asthma patients.

NCT ID: NCT02202122 Withdrawn - Clinical trials for Femoral Neck Fracture

Interest of the OSA (Obstructive Sleep Apnea) Predictive Scores in the Prognosis of Postoperative Mortality of Femoral Neck Fractures

Start date: September 2014
Phase: N/A
Study type: Observational [Patient Registry]

Interest of the four major OSA Predictive Scores (STOP-BANG, P-SAP, DES-OSA, OSA50) in the prognosis of postoperative mortality after femoral neck fracture.

NCT ID: NCT02198820 Withdrawn - Clinical trials for Femoral Neck Fractures

Practice Survey on Femoral Neck Fractures and the Incidence of Type of Anesthesia on Patient Outcome

Start date: October 2014
Phase: N/A
Study type: Observational [Patient Registry]

Inclusion of all patients with femoral neck fracture presenting in Saint-Luc Bouge Hospital between October 1th 2014 and September 30th 2015. Comparison of severity scores of these patients and the scale of Nottingham on immediate (day 1 and day 2) and late (1 month) outcome.

NCT ID: NCT02124785 Withdrawn - Hepatitis A Clinical Trials

Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®

Start date: May 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the long-term persistence of immunity to hepatitis A in adults who were vaccinated 21-25 years earlier with hepatitis A vaccine, Havrix®.